Physician

Tambrea Toylett Ellison, M.D.

According to 2025 Medicare claims, Tambrea Ellison, M.D. (NPI: 1306005202) practices pain management in the Valdosta, GA market, with the plurality of this provider's patient population coming from Lowndes, GA. This provider's primary affiliated billing organization is CARE MEDICAL CENTER LLC (NPI: 1063521250; TIN: 20-1846624) and primary practice location at 31602-5913.

Ellison's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 467 traditional Medicare patients, billed 19,088 HCPCS/CPT codes, and received $349,785 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 8,067 prescription claims across 785 beneficiaries totaling $416,255 in drug costs, led by Xtampza Er (Oxycodone Myristate). Open Payments data shows 13 records totaling $207. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $205,489 to $349,785. Similarly, Part D prescription costs have moved sharply higher in recent years, from $170,183 to $416,255. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	459	7,655	$205,489
2016	314	1,570	$101,531
2017	297	1,563	$116,785
2018	239	1,425	$104,739
2019	161	1,104	$88,297
2020	20	103	$3,353
2021	11	108	$2,776
2022	566	25,027	$668,333
2023	537	19,601	$563,464
2024	467	19,088	$349,785

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	795	2,940	$170,183
2016	216	1,633	$84,901
2017	224	1,876	$89,843
2018	218	1,924	$118,219
2019	247	1,804	$95,705
2020	189	2,652	$118,423
2021	217	3,483	$142,904
2022	847	10,029	$791,556
2023	895	10,784	$734,752
2024	785	8,067	$416,255

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	152	205	$242
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	560	$71
80307	Testing for presence of drug, by chemistry analyzers	191	387	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	283	668	$51
20610	Aspiration and/or injection of fluid from large joint	116	360	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	240	7,141	$93,922
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	2,096	62,402	$75,131
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,259	66,913	$66,244
Oxycontin	Oxycodone Hcl	115	3,304	$41,881
Ztlido	Lidocaine	34	2,760	$37,939

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$207	Collegium Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tambrea Toylett Ellison, M.D.?

Tedicare shows public-source Medicare data for Tambrea Toylett Ellison, M.D. (NPI 1306005202), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tambrea Toylett Ellison, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tambrea Toylett Ellison, M.D.?

Tambrea Toylett Ellison, M.D. is linked to CARE MEDICAL CENTER LLC (billing NPI 1063521250) in the available physician profile data.

Does Tambrea Toylett Ellison, M.D. have Open Payments data?

Tambrea Toylett Ellison, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.